TY  - CONF 
AU  - Gómez-Reino Carnota, Juan Jesús
PY  - 2014
SN  - 2326-5191
UR  - http://hdl.handle.net/20.500.11940/958
LA  - eng
TI  - Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (52-week) improvement in measures of disease activity in patients with psoriatic arthritis: Results from 3 phase 3, randomized, controlled trials
DO  - http://dx.doi.org/10.1002/art.38914
VL  - 66
ER  -